ID

34199

Description

An Observational Study of Case Managed Versus Non-case Managed Initiation of Hemodialysis; ODM derived from: https://clinicaltrials.gov/show/NCT01613404

Link

https://clinicaltrials.gov/show/NCT01613404

Keywords

  1. 1/15/19 1/15/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 15, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Chronic Kidney Disease NCT01613404

Eligibility Chronic Kidney Disease NCT01613404

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients who initiated hemodialysis and expected to be on hemodialysis for at least 1 year
Description

ID.1

Data type

boolean

patients initiating hemodialysis requiring treatment (erythropoiesis stimulating agent or red blood cell transfusion) to correct the anemia of chronic kidney disease who are receiving erythropoiesis stimulating agent treatment at study entry or patients who do not require erythropoiesis stimulating agent therapy (hb within or above target range)
Description

ID.2

Data type

boolean

life expectancy should be more than 12 months
Description

ID.3

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients contraindicated to receive erythropoiesis stimulating agent therapy (including but not limited to patients who develop pure red cell aplasia following treatment with any erythropoiesis stimulating agent )
Description

ID.4

Data type

boolean

patients entering the study on any other agent to increase red blood cell mass (such as androgen therapy, or investigational agents, or other non-approved erythropoiesis stimulating agent)
Description

ID.5

Data type

boolean

patients unwilling or unable to receive erythropoiesis stimulating agent therapy to correct the anemia of chronic kidney disease
Description

ID.6

Data type

boolean

patients with uncontrolled hypertension
Description

ID.7

Data type

boolean

patients who for any reason cannot receive adequate antithrombotic treatment
Description

ID.8

Data type

boolean

Similar models

Eligibility Chronic Kidney Disease NCT01613404

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients who initiated hemodialysis and expected to be on hemodialysis for at least 1 year
boolean
ID.2
Item
patients initiating hemodialysis requiring treatment (erythropoiesis stimulating agent or red blood cell transfusion) to correct the anemia of chronic kidney disease who are receiving erythropoiesis stimulating agent treatment at study entry or patients who do not require erythropoiesis stimulating agent therapy (hb within or above target range)
boolean
ID.3
Item
life expectancy should be more than 12 months
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
patients contraindicated to receive erythropoiesis stimulating agent therapy (including but not limited to patients who develop pure red cell aplasia following treatment with any erythropoiesis stimulating agent )
boolean
ID.5
Item
patients entering the study on any other agent to increase red blood cell mass (such as androgen therapy, or investigational agents, or other non-approved erythropoiesis stimulating agent)
boolean
ID.6
Item
patients unwilling or unable to receive erythropoiesis stimulating agent therapy to correct the anemia of chronic kidney disease
boolean
ID.7
Item
patients with uncontrolled hypertension
boolean
ID.8
Item
patients who for any reason cannot receive adequate antithrombotic treatment
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial